13F Filings History of Black Creek Investment Management Inc.

Latest 13F report
Q4 2025 - 13 Feb 2026
Value $
$2,015,983,041
Signature - Title
Miriam Lee - Chief Compliance Officer
Location
Toronto, Ontario, Canada
Summary
This page shows a list of all the recent 13F filings made by Black Creek Investment Management Inc.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Black Creek Investment Management Inc. reported 27 stock holdings with total value $2,015,983,041 as of Q4 2025. Top holdings included ELAN, BAH, PSMT, PYPL, and FCN.

Notify me when Black Creek Investment Management Inc. files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 27 $2,015,983,041 +$305,156,971 -$353,660,896 -$48,503,925 ELAN, BAH, PSMT, PYPL, FCN 13F-HR 13 Feb 2026, 12:37
Q3 2025 28 $2,120,641,162 +$188,901,464 -$416,668,859 -$227,767,395 HOLX, ELAN, BAH, PSMT, PYPL 13F-HR 12 Nov 2025, 14:48
Q2 2025 26 $2,163,501,656 +$146,684,527 -$345,873,006 -$199,188,479 ELAN, HOLX, NICE, BAH, PSMT 13F-HR 11 Aug 2025, 16:30
Q1 2025 26 $2,132,171,529 +$295,814,168 -$136,185,295 +$159,628,873 NICE, ELAN, HOLX, BIDU, BAH 13F-HR 13 May 2025, 12:44
Q4 2024 27 $2,114,457,545 +$158,603,621 -$671,719,041 -$513,115,420 NICE, ELAN, PYPL, NTR, BIDU 13F-HR 13 Feb 2025, 13:53
Q3 2024 29 $2,833,016,872 +$313,993,616 -$431,696,007 -$117,702,391 NICE, BIDU, PYPL, ELAN, NTR 13F-HR 13 Nov 2024, 13:06
Q2 2024 34 $2,687,428,268 +$135,726,665 -$485,488,013 -$349,761,348 IPG, NTR, ELAN, BIDU, PYPL 13F-HR 09 Aug 2024, 13:31
Q1 2024 37 $3,310,039,093 +$313,825,271 -$203,581,635 +$110,243,636 BIDU, IPG, ELAN, NTR, PYPL 13F-HR 15 May 2024, 12:36
Q4 2023 37 $3,050,532,773 +$214,373,803 -$153,243,427 +$61,130,376 ELAN, IPG, NICE, PYPL, ZBRA 13F-HR 13 Feb 2024, 10:40
Q3 2023 39 $2,745,732,905 +$207,333,376 -$102,154,499 +$105,178,877 NTR, BIDU, IPG, SRCL, PYPL 13F-HR 13 Nov 2023, 10:53
Q2 2023 38 $2,856,487,415 +$382,367,561 -$208,220,683 +$174,146,878 IPG, BIDU, ZBRA, NTR, PYPL 13F-HR 10 Aug 2023, 09:18
Q1 2023 38 $2,716,309,485 +$349,185,305 -$220,839,434 +$128,345,871 IPG, ZBRA, PYPL, BIDU, SRCL 13F-HR 09 May 2023, 11:19
Q4 2022 38 $2,344,897,910 +$199,746,290 -$453,205,567 -$253,459,277 IPG, BIDU, SRCL, PYPL, ZBRA 13F-HR 14 Feb 2023, 12:28
Q3 2022 2 $11,829,387 $0 $0 $0 VAREX IMAGING CORP, BOOKING HOLDINGS INC New Holdings 14 Feb 2023, 12:33
Q3 2022 40 $2,421,624,387 +$195,434,288 -$394,841,130 -$199,406,842 IPG, BIDU, BAH, SRCL, PYPL 13F-HR 09 Nov 2022, 12:02
Q2 2022 2 $11,953,573 $0 $0 $0 VAREX IMAGING CORP, BOOKING HOLDINGS INC New Holdings 14 Feb 2023, 12:32
Q2 2022 38 $2,792,161,573 +$428,452,039 -$934,336,318 -$505,884,279 BAH, BIDU, IPG, SRCL, PYPL 13F-HR 11 Aug 2022, 11:00
Q1 2022 2 $12,473,019 $0 $0 $0 VAREX IMAGING CORP, BOOKING HOLDINGS INC New Holdings 14 Feb 2023, 12:32
Q1 2022 36 $3,550,806,019 +$227,788,394 -$450,426,587 -$222,638,193 BAH, IPG, BIDU, GSK, NTR 13F-HR 06 May 2022, 07:37
Q4 2021 2 $16,385,569 $0 $0 $0 VAREX IMAGING CORP, BOOKING HOLDINGS INC New Holdings 14 Feb 2023, 12:31
Q4 2021 35 $3,751,132,569 +$629,184,123 -$409,753,257 +$219,430,866 BAH, GSK, IPG, BIDU, NTR 13F-HR 15 Feb 2022, 10:30
Q3 2021 2 $15,149,139 $0 $0 $0 VAREX IMAGING CORP, BOOKING HOLDINGS INC New Holdings 14 Feb 2023, 12:30
Q3 2021 35 $3,443,415,139 +$517,058,609 -$250,745,787 +$266,312,822 BAH, IPG, GSK, BIDU, IBN 13F-HR 05 Nov 2021, 10:22
Q2 2021 2 $14,583,962 $0 $0 $0 VAREX IMAGING CORP, BOOKING HOLDINGS INC New Holdings 14 Feb 2023, 12:29
Q2 2021 36 $3,234,155,962 +$323,678,963 -$285,243,080 +$38,435,883 BAH, IPG, GSK, BIDU, ORCL 13F-HR 12 Aug 2021, 16:59
Q1 2021 31 $3,019,384,000 +$470,824,289 -$915,595,186 -$444,770,897 BAH, IPG, ORCL, GSK, IBN 13F-HR 06 May 2021, 11:07
Q4 2020 33 $3,209,079,000 +$294,280,751 -$345,896,509 -$51,615,758 IPG, NTR, IBN, BIDU, GSK 13F-HR 08 Feb 2021, 16:09
Q3 2020 31 $2,630,634,000 +$175,364,464 -$171,459,708 +$3,904,756 NTR, IPG, BIDU, GSK, BAH 13F-HR 09 Nov 2020, 11:26
Q2 2020 31 $2,475,741,000 +$98,811,431 -$416,499,988 -$317,688,557 IPG, NTR, BWA, GSK, IBN 13F-HR 11 Aug 2020, 12:09
Q1 2020 32 $2,489,026,000 +$464,983,932 -$405,161,095 +$59,822,837 NTR, IPG, GSK, ORCL, BWA 13F-HR 08 May 2020, 11:16
Q4 2019 32 $3,183,934,000 +$242,297,770 -$137,490,739 +$104,807,031 GSK, IPG, IBN, NTR, ORCL 13F-HR 11 Feb 2020, 16:37
Q3 2019 32 $2,859,133,000 +$306,064,976 -$425,891,117 -$119,826,141 GSK, ORCL, IPG, IBN, NLSN 13F-HR 12 Nov 2019, 10:58
Q2 2019 31 $3,034,339,000 +$369,275,422 -$396,050,474 -$26,775,052 GSK, BWA, ORCL, IPG, BSMX 13F-HR 13 Aug 2019, 14:09
Q1 2019 27 $2,930,052,000 +$192,001,416 -$318,354,928 -$126,353,512 GSK, BAH, BSMX, IBN, NLSN 13F-HR 13 May 2019, 12:26
Q4 2018 26 $2,763,282,000 +$120,706,124 -$280,649,033 -$159,942,909 GSK, BSMX, IBN, NLSN, ORCL 13F-HR 12 Feb 2019, 10:41
Q3 2018 26 $3,285,566,000 +$105,904,482 -$272,337,430 -$166,432,948 BSMX, ORCL, IBN, BAH, NLSN 13F-HR 09 Nov 2018, 11:02
Q2 2018 28 $3,279,688,000 +$336,322,714 -$158,296,622 +$178,026,092 IBN, ORCL, BAH, NLSN, BSMX 13F-HR 13 Aug 2018, 13:46
Q1 2018 28 $3,056,804,000 +$961,919,802 -$372,995,948 +$588,923,854 IBN, BSMX, ORCL, NLSN, BAH 13F-HR 11 May 2018, 10:26
Q4 2017 27 $2,657,030,000 +$544,784,221 -$125,487,812 +$419,296,409 IBN, ORCL, NLSN, BSMX, BAH 13F-HR 09 Feb 2018, 10:42
Q3 2017 26 $2,268,095,000 +$384,130,821 -$88,712,663 +$295,418,158 IBN, NLSN, ORCL, BSMX, INOV 13F-HR 13 Nov 2017, 10:25
Q2 2017 23 $1,886,321,000 +$386,377,434 -$107,600,933 +$278,776,501 IBN, ORCL, BSMX, NLSN, FCN 13F-HR 14 Aug 2017, 14:23
Q1 2017 19 $1,591,062,000 +$251,204,221 -$124,139,140 +$127,065,081 IBN, BSMX, ORCL, FCN, NLSN 13F-HR 15 May 2017, 11:15
Q4 2016 18 $1,299,597,000 +$182,963,290 -$75,292,701 +$107,670,589 IBN, FCN, ORCL, BSMX, GRFS 13F-HR 14 Feb 2017, 10:24
Q3 2016 18 $1,232,651,000 +$93,699,199 -$60,359,386 +$33,339,813 IBN, FCN, ORCL, BSMX, CCL 13F-HR 14 Nov 2016, 11:27
Q2 2016 18 $1,171,564,000 $0 $0 $0 IBN, ORCL, BSMX, FCN, INOV New Holdings 16 Aug 2016, 16:35
Q2 2016 18 $1,171,564,000 +$153,389,740 -$106,325,854 +$47,063,886 IBN, ORCL, BSMX, FCN, INOV 13F-HR 12 Aug 2016, 13:03
Q1 2016 19 $1,132,577,000 +$191,159,829 -$55,708,088 +$135,451,741 IBN, ORCL, FCN, BSMX, HAE 13F-HR 13 May 2016, 10:14
Q4 2015 18 $985,264,000 +$260,824,515 -$53,478,596 +$207,345,919 ORCL, IBN, FCN, BSMX, TV 13F-HR 16 Feb 2016, 11:30
Q3 2015 18 $759,764,000 +$161,418,251 -$125,577,564 +$35,840,687 FCN, ORCL, CCL, HAE, IBN 13F-HR 13 Nov 2015, 11:06
Q2 2015 17 $815,329,000 +$77,475,819 -$100,291,515 -$22,815,696 FCN, CCL, ORCL, HAE, IBN 13F-HR 14 Aug 2015, 12:49
Q1 2015 18 $824,483,000 +$61,857,298 -$69,949,053 -$8,091,755 FCN, CCL, ORCL, TV, HAE 13F-HR 11 May 2015, 12:48
Q4 2014 17 $809,483,000 +$79,400,753 -$129,606,344 -$50,205,591 FCN, ORCL, CCL, EBAY, TV 13F-HR 04 Feb 2015, 13:40
Q3 2014 16 $869,664,000 +$24,412,782 -$65,666,509 -$41,253,727 TV, ORCL, CCL, EBAY, FCN 13F-HR 14 Nov 2014, 10:17
Q2 2014 16 $951,644,000 +$135,089,427 -$81,753,655 +$53,335,772 TV, ORCL, FCN, CCL, EBAY 13F-HR 14 Aug 2014, 10:23
Q1 2014 17 $914,519,000 +$187,707,268 -$99,703,820 +$88,003,448 TV, ORCL, CCL, FCN, MR 13F-HR 14 May 2014, 16:05
Q4 2013 17 $849,846,000 $0 $0 $0 WX, ORCL, CCL, TV, FCN 13F-HR 13 Feb 2014, 10:44